BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3146827)

  • 21. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.
    Wu B; Zhou S; Song L; Liu X
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):364-6. PubMed ID: 12408765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Allogenic bone marrow transplantation in acute leukemias and chronic myeloid leukemia].
    Mendeleeva LP
    Ter Arkh; 2003; 75(7):89-94. PubMed ID: 12934492
    [No Abstract]   [Full Text] [Related]  

  • 23. Leukemias and myeloma.
    Wiernik PH
    Cancer Chemother Biol Response Modif; 1996; 16():347-75. PubMed ID: 8639390
    [No Abstract]   [Full Text] [Related]  

  • 24. Leukemias and plasma cell myeloma.
    Wiernik PH
    Cancer Chemother Biol Response Modif; 1997; 17():390-407. PubMed ID: 9551222
    [No Abstract]   [Full Text] [Related]  

  • 25. [The molecular biology diagnosis of neoplastic blood diseases].
    Teleheiev HD; Dybkov MV; Bozhko MV; Tretiak NM; Maliuta SS
    Tsitol Genet; 1998; 32(1):71-8. PubMed ID: 9695255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukemias and plasma cell myeloma.
    Wiernik PH
    Cancer Chemother Biol Response Modif; 1999; 18():268-92. PubMed ID: 10800488
    [No Abstract]   [Full Text] [Related]  

  • 27. The spectrum of adult B-lymphoid leukemias with BCR-ABL: molecular diagnostic, cytogenetic, and clinical laboratory perspectives.
    Klco JM; Kreisel FH; Zehnbauer BA; Kulkarni S; Hassan A; Frater JL
    Am J Hematol; 2008 Dec; 83(12):901-7. PubMed ID: 18932238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
    Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
    Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathological features of neuroleukemia. Changes and lessons].
    Garzuly F
    Orv Hetil; 1994 Jun; 135(24):1291-5. PubMed ID: 8015823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms of Bcr-Abl-induced oncogenesis.
    Gishizky ML
    Cytokines Mol Ther; 1996 Dec; 2(4):251-61. PubMed ID: 9384712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Usefulness of molecular screening in childhood lymphoblastic leukemias].
    Anguita E; González FA; Contra T; Martín N; Valverde F; Villegas A
    Sangre (Barc); 1998 Feb; 43(1):7-11. PubMed ID: 9577176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history of acute lymphoblastic leukemia in neurofibromatosis type 1 monozygotic twins.
    Galbiati M; Lettieri A; Micalizzi C; Songia S; Morerio C; Biondi A; Dufour C; Cazzaniga G
    Leukemia; 2013 Aug; 27(8):1778-81. PubMed ID: 23426165
    [No Abstract]   [Full Text] [Related]  

  • 33. Both gram positive and gram negative organisms complicate neutropaenic sepsis in children with leukemia. A unit audit study and recommendation.
    Lee KY; Chan WS; Koay LS; Huang F; Tan LM; Yeoh AE
    Ann Acad Med Singap; 2003 Sep; 32(5 Suppl):S37-8. PubMed ID: 14968729
    [No Abstract]   [Full Text] [Related]  

  • 34. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
    Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
    Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Philadelphia chromosome-positive acute lymphoblastic leukemia after therapy for Langerhans cell histiocytosis.
    Tatsumi T; Shimazaki C; Araki SI; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Fujita N; Nakagawa M; Misawa SI; Imashuku S
    Am J Hematol; 1997 Jan; 54(1):88. PubMed ID: 8980271
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence of population mixing based on the geographical distribution of childhood leukemia in Ohio.
    Clark BR; Ferketich AK; Fisher JL; Ruymann FB; Harris RE; Wilkins JR
    Pediatr Blood Cancer; 2007 Nov; 49(6):797-802. PubMed ID: 17366525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal smoking and childhood leukemia and lymphoma risk among 1,440,542 Swedish children.
    Mucci LA; Granath F; Cnattingius S
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1528-33. PubMed ID: 15342456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Detection of the Mbcr/abl translocation using FISH in bone marrow samples from patients diagnosed with CML and ALL].
    Vargas MT; Fernández-Novoa MC; García-Creus MD; González-Ruano J
    Sangre (Barc); 1996 Oct; 41(5):399-400. PubMed ID: 9026927
    [No Abstract]   [Full Text] [Related]  

  • 39. StatBite: Estimated new cases for the four major leukemias, 2008.
    J Natl Cancer Inst; 2009 Mar; 101(6):371. PubMed ID: 19276455
    [No Abstract]   [Full Text] [Related]  

  • 40. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.
    Williams RT; Sherr CJ
    Cold Spring Harb Symp Quant Biol; 2008; 73():461-7. PubMed ID: 19028987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.